more about managing osteoporosis and promoting adherence with "bisphosphonate" meds (alendronate, etc)

October 2013

You'll hear more about managing osteoporosis and promoting adherence with "bisphosphonate" meds (alendronate, etc).

About 50% of patients on a bisphosphonate stop after one year...due to side effects, cost, dosing schedules, or not feeling the drug working.

This can lead to worsening bone loss...and fractures.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Practice ways to improve workflow in the pharmacy
Vaccines new versions of the flu vaccine this season
Osteoporosis more about managing osteoporosis and promoting adherence with "bisphosphonate" meds (alendronate, etc)
Dermatology Recent warnings about acetaminophen will bring up questions about serious drug-induced skin reactions
Allergic Reactions more "cephalosporin" antibiotics (cefdinir, etc) used to treat respiratory infections in patients allergic to penicillin
Veterinary Medicine handling orders for pet meds
Liver Disease myths about using certain meds in patients with chronic liver disease (cirrhosis, hepatitis, etc)
Malaria changes in the treatments used for preventing malaria
Antithrombotics how to prevent and treat warfarin-induced bleeding
Interactions preventing drug interactions